Authors: HONEYCHURCH J CRUISE A TUTT AL GLENNIE MJ

Citation: J. Honeychurch et al., BISPECIFIC AB THERAPY OF B-CELL LYMPHOMA - TARGET-CELL SPECIFICITY OFANTIBODY DERIVATIVES APPEARS CRITICAL IN DETERMINING THERAPEUTIC OUTCOME, Cancer immunology and immunotherapy, 45(3-4), 1997, pp. 171-173